Allogeneic HPV-specific T cells

HPV-specific allogeneic T cells · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic HPV-specific T cells, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers [Phase 1, Phase 2]

See pricing